Therapy Approved for All Types of Severe Asthma

Email citation

Your saved search

Your RSS Feed

. 2022 Mar 1;327(9):805.

doi: 10.1001/jama.2022.1875.

Howard D Larkin. JAMA. 2022.

. 2022 Mar 1;327(9):805.

doi: 10.1001/jama.2022.1875.

No abstract available

Similar articles

Development of New Therapies for Severe Asthma.
Fajt ML, Wenzel SE. Fajt ML, et al. Allergy Asthma Immunol Res. 2017 Jan;9(1):3-14. doi: 10.4168/aair.2017.9.1.3. Allergy Asthma Immunol Res. 2017. PMID: 27826957 Free PMC article. Review.
Monoclonal Antibody Therapy in Childhood Asthma.
Tison KL, Patrawala M, Blaiss MS. Tison KL, et al. Curr Allergy Asthma Rep. 2020 May 19;20(7):26. doi: 10.1007/s11882-020-00919-3. Curr Allergy Asthma Rep. 2020. PMID: 32430808 Review.
Biological therapies targeting the type 2 inflammatory pathway in severe asthma (Review).
Fildan AP, Rajnoveanu RM, Cirjaliu R, Pohrib I, Tudorache E, Ilie AC, Oancea C, Tofolean D. Fildan AP, et al. Exp Ther Med. 2021 Nov;22(5):1263. doi: 10.3892/etm.2021.10698. Epub 2021 Sep 6. Exp Ther Med. 2021. PMID: 34603531 Free PMC article. Review.
Treatment for Severe Asthma in Children: What About Biologics?
Pansare M, Seth D, Kamat D, Poowuttikul P. Pansare M, et al. Pediatr Ann. 2021 May;50(5):e206-e213. doi: 10.3928/19382359-20210420-01. Epub 2021 May 1. Pediatr Ann. 2021. PMID: 34044704
Biologic Therapy and Novel Molecular Targets of Severe Asthma.
Pepper AN, Renz H, Casale TB, Garn H. Pepper AN, et al. J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):909-916. doi: 10.1016/j.jaip.2017.04.038. J Allergy Clin Immunol Pract. 2017. PMID: 28689841 Review.